Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 3, 2012, Pages 712-718

  Fortuin, Ansje S ^a   Deserno, Willem M L L G ^a   Meijer, Hanneke J M ^a   Jager, Gerrit J ^b   Takahashi, Satoru ^a   Debats, Oscar A ^a   Reske, Sven N ^c   Schick, Christian ^c   Krause, Bernd J ^d   Van Oort, Inge ^a   Witjes, Alfred J ^a   Hoogeveen, Yvonne L ^a   Van Lin, Emile N J Th ^a   Barentsz, Jelle O ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JEROEN BOSCH HOSPITAL   (Netherlands)

^c UNIVERSITY OF ULM   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

11C choline PET CT; Computed tomography; Lymph node; Magnetic resonance imaging; MRI; Positron emission tomography; Prostate cancer; Ultra small super paramagnetic iron oxide nanoparticles

Indexed keywords

11C-CHOLINE PET/CT; COMPUTED TOMOGRAPHY; LYMPH NODE; PROSTATE CANCERS; ULTRA-SMALL;

BODY FLUIDS; DISEASES; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; PARAMAGNETISM; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY;

COMPUTERIZED TOMOGRAPHY;

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; LYMPH NODE METASTASIS; LYMPHOGRAPHY; MAGNETIC RESONANCE LYMPHOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE DISTRIBUTION;

AGED; CARBON RADIOISOTOPES; CHOLINE; CONTRAST MEDIA; DEXTRANS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOGRAPHY; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOTHERAPY, IMAGE-GUIDED;

EID: 84866729467     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.12.093     Document Type: Article

References (20)

1. L.K. Morikawa, and M. Roach III Pelvic nodal radiotherapy in patients with unfavourable intermediate and high-risk prostate cancer: Evidence, rationale, and future directions Int J Radiat Oncol Biol Phys 80 2011 6 16
2. G. Mantini, L. Tagliaferri, and G.C. Mattiucci Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy Int J Radiat Oncol Biol Phys 81 2011 721 726
3. U. Ganswindt, D. Schilling, and A.C. Muller Distribution of prostate sentinel nodes: A SPECT-derived anatomic atlas Int J Radiat Oncol Biol Phys 79 2011 1354 1372
4. C.R. Pound, A.W. Partin, and M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
5. W.M. Deserno, O.A. Debats, and T. Rozema Comparison of nodal risk formula and MR lymphography for predicting lymph node involvement in prostate cancer Int J Radiat Oncol Biol Phys 81 2011 8 15
6. A.M. Hövels, R.A.M. Heesakkers, and E.M. Adang The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: A meta-analysis Clin Radiol 63 2008 387 395
7. M.G. Harisinghani, J.O. Barentsz, and P.F. Hahn Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N Engl J Med 348 2003 2491 2499
8. R.A.M. Heesakkers, A.M. Hövels, and G.J. Jager MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: A prospective multicohort study Lancet Oncol 9 2008 850 856
9. O. Will, S. Purkayastha, and C. Chan Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: A meta-analysis Lancet Oncol 7 2006 52 60
10. E. Ackerstaff, K. Glunde, and Z.M. Bhujwalla Choline phospholipid metabolism: A target in cancer cells? J Cell Biochem 90 2003 525 533
11. 11C-choline PET J Nucl Med 44 2003 331 335
12. M. Scattoni Picchio, N. Suardi, and C. Messa Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: Results confirmed by open pelvic-retroperitoneal lymphadenectomy Eur Urol 52 2007 423 429
13. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: Comparison with clinical staging nomograms Eur Urol 54 2008 392 401
14. C.A. Lawton, J. Michalski, and I. El-Naqa RTOG GU radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer Int J Radiat Oncol Biol Phys 74 2009 383 387
15. 1-weighted magnetization prepared rapid gradient-echo sequence AJR Am J Roentgenol 167 1996 1503 1507
16. 2-weighted MR imaging at 1.5 and 3.0 T: Early experience Radiology 239 2006 481 487
17. M.V. Meng, and P.R. Carroll When is lymph node dissection necessary before radical prostatectomy? A decision analysis J Urol 164 2000 1235 1240
18. L.F. Da Pozzo, C. Cozzarini, and A. Briganti Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: The positive impact of adjuvant radiotherapy Eur Urol 55 2009 1003 1010
19. H.J. Meijer, O.A. Debats, and M. Kunze-Busch Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer Int J Radiat Oncol Biol Phys 77 2010 1066 1071
20. J.B. Adkison, D.R. McHaffie, and S.M. Bentzen Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer Int J Radiat Oncol Biol Phys 82 2012 184 190